Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 20

1.

Distinct Subpopulations of Intravalvular Methicillin-Resistant Staphylococcus aureus With Variable Susceptibility to Daptomycin in Tricuspid Valve Endocarditis.

Miller CR, Dey S, Smolenski PD, Kulkarni PS, Monk JM, Szubin R, Sakoulas G, Berti AD.

Antimicrob Agents Chemother. 2020 Jan 13. pii: AAC.01593-19. doi: 10.1128/AAC.01593-19. [Epub ahead of print]

PMID:
31932377
2.

Tolerance to antibiotics affects response.

Berti AD, Hirsch EB.

Science. 2020 Jan 10;367(6474):141-142. doi: 10.1126/science.aba0150. No abstract available.

PMID:
31919206
3.

Reduced Production of Bacterial Membrane Vesicles Predicts Mortality in ST45/USA600 Methicillin-Resistant Staphylococcus aureus Bacteremia.

Dey S, Gudipati S, Giuliano C, Zervos MJ, Monk JM, Szubin R, Jorgensen SCJ, Sakoulas G, Berti AD.

Antibiotics (Basel). 2019 Dec 18;9(1). pii: E2. doi: 10.3390/antibiotics9010002.

4.

Meningococcal serogroup B outbreak response University of Wisconsin-Madison.

Ritscher AM, Ranum N, Malak JD, Ahrabi-Fard S, Baird J, Berti AD, Curtis W, Holden M, Jones CD, Kind J, Kinsey W, Koepke R, Schauer SL, Stein E, Van Orman S, Ward BG, Zahner SJ, Hayney MS.

J Am Coll Health. 2019 Apr;67(3):191-196. doi: 10.1080/07448481.2018.1469502. Epub 2018 Sep 19.

PMID:
29952729
5.

Daptomycin selects for genetic and phenotypic adaptations leading to antibiotic tolerance in MRSA.

Berti AD, Shukla N, Rottier AD, McCrone JS, Turner HM, Monk IR, Baines SL, Howden BP, Proctor RA, Rose WE.

J Antimicrob Chemother. 2018 Aug 1;73(8):2030-2033. doi: 10.1093/jac/dky148.

6.

Combination Antibiotic Exposure Selectively Alters the Development of Vancomycin Intermediate Resistance in Staphylococcus aureus.

Zheng X, Berti AD, McCrone S, Roch M, Rosato AE, Rose WE, Chen B.

Antimicrob Agents Chemother. 2018 Jan 25;62(2). pii: e02100-17. doi: 10.1128/AAC.02100-17. Print 2018 Feb.

7.

Increased Endovascular Staphylococcus aureus Inoculum Is the Link Between Elevated Serum Interleukin 10 Concentrations and Mortality in Patients With Bacteremia.

Rose WE, Shukla SK, Berti AD, Hayney MS, Henriquez KM, Ranzoni A, Cooper MA, Proctor RA, Nizet V, Sakoulas G.

Clin Infect Dis. 2017 May 15;64(10):1406-1412. doi: 10.1093/cid/cix157. Erratum in: Clin Infect Dis. 2017 Oct 15;65(8):1431-1433.

8.

Penicillin Binding Protein 1 Is Important in the Compensatory Response of Staphylococcus aureus to Daptomycin-Induced Membrane Damage and Is a Potential Target for β-Lactam-Daptomycin Synergy.

Berti AD, Theisen E, Sauer JD, Nonejuie P, Olson J, Pogliano J, Sakoulas G, Nizet V, Proctor RA, Rose WE.

Antimicrob Agents Chemother. 2015 Nov 2;60(1):451-8. doi: 10.1128/AAC.02071-15. Print 2016 Jan.

9.

Heterogeneity of genetic pathways toward daptomycin nonsusceptibility in Staphylococcus aureus determined by adjunctive antibiotics.

Berti AD, Baines SL, Howden BP, Sakoulas G, Nizet V, Proctor RA, Rose WE.

Antimicrob Agents Chemother. 2015 May;59(5):2799-806. doi: 10.1128/AAC.04990-14. Epub 2015 Mar 2.

10.

Compatibility of cefepime and vancomycin during simulated Y-site administration of prolonged infusion.

Berti AD, Hutson PR, Schulz LT, Webb AP, Rose WE.

Am J Health Syst Pharm. 2015 Mar 1;72(5):390-5. doi: 10.2146/ajhp140369.

PMID:
25694414
11.

β-Lactam antibiotics targeting PBP1 selectively enhance daptomycin activity against methicillin-resistant Staphylococcus aureus.

Berti AD, Sakoulas G, Nizet V, Tewhey R, Rose WE.

Antimicrob Agents Chemother. 2013 Oct;57(10):5005-12. doi: 10.1128/AAC.00594-13. Epub 2013 Jul 29.

12.

Relationship of in vitro synergy and treatment outcome with daptomycin plus rifampin in patients with invasive methicillin-resistant Staphylococcus aureus infections.

Rose WE, Berti AD, Hatch JB, Maki DG.

Antimicrob Agents Chemother. 2013 Jul;57(7):3450-2. doi: 10.1128/AAC.00325-12. Epub 2013 May 6.

13.

Addition of ceftaroline to daptomycin after emergence of daptomycin-nonsusceptible Staphylococcus aureus during therapy improves antibacterial activity.

Rose WE, Schulz LT, Andes D, Striker R, Berti AD, Hutson PR, Shukla SK.

Antimicrob Agents Chemother. 2012 Oct;56(10):5296-302. doi: 10.1128/AAC.00797-12. Epub 2012 Aug 6.

14.

Altering the proclivity towards daptomycin resistance in methicillin-resistant Staphylococcus aureus using combinations with other antibiotics.

Berti AD, Wergin JE, Girdaukas GG, Hetzel SJ, Sakoulas G, Rose WE.

Antimicrob Agents Chemother. 2012 Oct;56(10):5046-53. doi: 10.1128/AAC.00502-12. Epub 2012 Jul 16.

15.

Analysis of achromobactin biosynthesis by Pseudomonas syringae pv. syringae B728a.

Berti AD, Thomas MG.

J Bacteriol. 2009 Jul;191(14):4594-604. doi: 10.1128/JB.00457-09. Epub 2009 May 29.

16.

Nonribosomal peptide synthetases involved in the production of medically relevant natural products.

Felnagle EA, Jackson EE, Chan YA, Podevels AM, Berti AD, McMahon MD, Thomas MG.

Mol Pharm. 2008 Mar-Apr;5(2):191-211. doi: 10.1021/mp700137g. Epub 2008 Jan 25. Review.

17.
18.

Identification of the biosynthetic gene cluster and an additional gene for resistance to the antituberculosis drug capreomycin.

Felnagle EA, Rondon MR, Berti AD, Crosby HA, Thomas MG.

Appl Environ Microbiol. 2007 Jul;73(13):4162-70. Epub 2007 May 11.

19.

[X-ray image of the sella turcica in vitiligo].

TELLO EE, BERTI AD.

Rev Fac Cienc Med Cordoba. 1957 Jul-Sep;15(3):149-53. Spanish. No abstract available.

PMID:
13528023
20.

Radiological visualization of the biliary ducts with telepaque.

BERTI AD, POSSE DR.

Am J Roentgenol Radium Ther Nucl Med. 1956 Feb;75(2):354-9. No abstract available.

PMID:
13283191

Supplemental Content

Loading ...
Support Center